Jalota Deepika
- SEC CIK
- 0001825192
No open-market purchases or sales filed in the past year.
Current role at each company
- PMVP PMV Pharmaceuticals, Inc.Chief Development Officeras of Mar 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jalota Deepika as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Jalota DeepikaChief Development Officer | SSale | −33.1K | $1.06 | −$35.0K | −26.9%90.0K after | |
| Sep 12, 2024 (view filing) | Sep 11 | 1 day | Jalota DeepikaChief Development Officer | SSale | −7.22K | $1.50 | −$10.8K | −5.8%118.3K after | |
| Sep 18, 2023 (view filing) | Sep 15 | 3 days | Jalota DeepikaChief Development Officer | SSale | −4.10K | $6.62 | −$27.2K | −12.1%29.9K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Jalota DeepikaSVP, Regulatory Affairs and QA | SSale | −2.90K | $33.78 | −$97.8K | −100.0%0 after |